Home » Topics » BioWorld Science

BioWorld Science
RSS

Turnstone Biologics collaborates with University of Montreal for development of TIL therapy

April 26, 2022

Origo Biopharma discloses new TGFBR1 inhibitors

April 26, 2022

Jiangsu Chia Tai Tianqing Pharmaceutical researchers synthesize new AKT inhibitors

April 26, 2022

Shenzhen Salubris Pharmaceuticals presents GLP-1 receptor agonists

April 26, 2022

Duality Biologics divulges new ADCs for cancer

April 26, 2022

BeiGene patents new MAP4K1 inhibitors

April 26, 2022

Discovery of novel oridonin analogues as potent anticancer agents

April 26, 2022

ZLD-2218, a novel BRD4 inhibitor for the treatment of kidney fibrosis

April 26, 2022

TNIK as novel therapeutic target in lung squamous cell carcinoma

April 26, 2022

CDK4/6 inhibitor PRT-3645 prolongs survival in glioblastoma and brain-metastatic breast cancers

April 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...